Close X
Wednesday, December 4, 2024
ADVT 
National

Lululemon says Omicron impacting sales, profits

Darpan News Desk The Canadian Press, 10 Jan, 2022 04:54 PM
  • Lululemon says Omicron impacting sales, profits

VANCOUVER - Lululemon Athletica Inc. is lowering its fourth-quarter earnings estimates as the Omicron variant curbs the retailer's sales.

The Vancouver-based company says it now expects its net revenue and earnings to be on the low end of previously announced ranges.

Calvin McDonald, CEO of the athletic apparel retailer, says Lululemon started the holiday season in a strong position.

But he says the company has since experienced several consequences as a result of the surge in COVID-19 cases and changing restrictions.

He says Lululemon has been impacted by increased capacity constraints in stores, more limited staff availability and reduced operating hours in some locations.

David Swartz, an equity analyst at Morningstar, says Lululemon has consistently smashed sales and earnings expectations over the past three years, making it surprising to see any weakness emerge.

While he says one mild earnings miss does not materially impact valuation, the financial services firm has long had concerns that Lululemon is significantly overvalued

In a client note last March, Morningstar said Lululemon’s valuation "is as stretched as its leggings."

Lululemon’s share price dropped a little more than six per cent following Monday's announcement, and was down roughly 30 per cent from its all-time high in November.

The company's shares were trading for about US$333.30 midday on the Nasdaq composite. Swartz says Morningstar's fair value estimate is US$193.

Lululemon says it expects the company’s net revenue to be toward the low end of its range of US$2.125 billion to US$2.165 billion.

It expects diluted earnings per share and adjusted diluted earnings per share to be toward the low end of its ranges of US$3.24 to US$3.31 and US$3.25 to US$3.32, respectively.

MORE National ARTICLES

Champagne's D.C. takeaway: more meetings

Champagne's D.C. takeaway: more meetings
Champagne says the two sides talked about how to strengthen cross-border supply chains, the potential role of Canada's critical-minerals industry and meeting shared climate goals.

Champagne's D.C. takeaway: more meetings

BC Wildfire Service releases 2021 wildfire summary

BC Wildfire Service releases 2021 wildfire summary
A 2021 wildfire summary says about $565 million was spent in the "tremendously challenging" period between April 1 and Sept. 30, when 1,610 wildfires charred 8,682 square kilometres, mainly in southern and southeastern B.C.

BC Wildfire Service releases 2021 wildfire summary

Growth was cancerous in B.C. premier's throat

Growth was cancerous in B.C. premier's throat
British Columbia Premier John Horgan says a biopsy has shown a growth in his throat was cancerous. In a statement Thursday, he said his prognosis is good and he expects to make a full recovery.

Growth was cancerous in B.C. premier's throat

Apple CEO Tim Cook sends Diwali message to Indians

Apple CEO Tim Cook sends Diwali message to Indians
The year 2021 has been exceptionally good for Apple in India and despite supply constraints, the tech giant doubled its India market share in its fiscal year that ended on September 30, Cook had recently announced.

Apple CEO Tim Cook sends Diwali message to Indians

Growth in health spending tripled in 2020: CIHI

Growth in health spending tripled in 2020: CIHI
Health spending is projected to have increased 12.8 per cent between 2019 and 2020. That's more than triple the average annual growth rate seen from 2015 to 2019, which was approximately four per cent per year. Spending is estimated to have increased another 2.2 per cent between 2020 and 2021.    

Growth in health spending tripled in 2020: CIHI

Pricey COVID-19 test at border called 'irrational'

Pricey COVID-19 test at border called 'irrational'
All travellers over the age of five, regardless of citizenship or vaccination status, must provide proof of a negative COVID-19 molecular test in order to enter the country. It can cost between $150 and $300, making it prohibitively expensive for many families.

Pricey COVID-19 test at border called 'irrational'